A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
Incyte Corporation
Incyte Corporation
Incyte Corporation
University of Alabama at Birmingham
National Cancer Institute (NCI)
Incyte Corporation
Incyte Corporation
University of Rochester
Merck Sharp & Dohme LLC
Prelude Therapeutics
University of Southern California
City of Hope Medical Center
Incyte Corporation
University Hospital, Brest
Icahn School of Medicine at Mount Sinai
Center for International Blood and Marrow Transplant Research
University of Washington
Masonic Cancer Center, University of Minnesota
University of California, Irvine
City of Hope Medical Center
Disc Medicine, Inc
University Hospital, Angers
Fred Hutchinson Cancer Center
Azienda Ospedaliero-Universitaria di Parma
MPN Research Foundation